Macrophage metabolic exhaustion and PANoptotic cell death drive chronic tissue inflammation in rheumatoid arthritis

Read full text
Authors: Tao Huang, Yoshinori Takashima, Jitendra Kumar, Jose Morales, Kevin X. Le, Zhensheng Hu, Selene Rubino, Robert T. Trousdale, Gerald J. Berry, Jorg J. Goronzy, Cornelia M. Weyand
Cited by: 10
References: 81

Abstract

In the autoimmune disease rheumatoid arthritis, the inflammatory response evolves from protective to pathogenic, causing tissue destruction. Rheumatoid synovitis persists despite the presence of pro-repair SELENOP hi MerTK + CD206 + macrophages, suggesting that these cells acquire pro-arthritogenic functions. Patient-derived synovial SELENOP hi MerTK + CD206 + macrophages produced high concentrations of the complement component C1q and concurrently expressed its receptor, C1QBP. Stimulation of these macrophages with C1q induced metabolic exhaustion, characterized by diminished ATP production, cleavage of mitochondrial nicotinamide adenine dinucleotide (NAD), and accumulation of cyclic ADP ribose (cADPR). This metabolic crisis was driven by the mitochondrial enzyme Sterile alpha and Toll/interleukin-1 receptor (TIR) motif containing 1 (SARM1), which catalyzed the conversion of NAD into cADPR, triggering PANoptotic and pro-inflammatory macrophage death. In vivo experiments demonstrated that C1q treatment exacerbated synovitis, whereas SARM1 inhibition conferred therapeutic benefit. These findings identify the NAD + hydrolase SARM1 as a marker of metabolically stressed macrophages and an executor of pro-inflammatory macrophage death during autoimmune tissue inflammation.

Fields of Study & Subjects

Rheumatoid Arthritis Research and Therapies Immune cells in cancer Adipokines Inflammation and Metabolic Diseases

Publication details

Journal / source
Immunity
Publisher
Elsevier BV
Volume
59
Issue
4
Pages
970–987.e6
Publication date
7 March 2026
Language
EN